Management Team and Scientific Advisory Board extension

Gaudenz von Capeller appointed Chief Financial Officer.
Professor Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC), appointed as Chairman of the Scientific Advisory Board. See our Press Release.